EVALUATION OF PRIDOPIDINE IN THE TRANSGENIC YAC128 MOUSE MODEL OF HUNTINGTON'S DISEASE

被引:0
|
作者
Miralles, Marta Garcia [1 ]
Tan, Liang Juin [1 ]
Lim, Madeline [1 ]
Geva, Michal [2 ]
Hayden, Michael R. [1 ,2 ,3 ,4 ]
Pouladi, Mahmoud A. [1 ,3 ,4 ]
机构
[1] Translat Lab Genet Med, Singapore, Singapore
[2] Teva Pharmaceut, Res & Dev, Netanya, Israel
[3] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC, Canada
[4] Natl Univ Singapore, Dept Med, Yong Loo Lin Sch Med, Singapore, Singapore
关键词
D O I
10.1136/jnnp-2016-314597.261
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
L6
引用
收藏
页码:A92 / A92
页数:1
相关论文
共 50 条
  • [21] Selective degeneration and nuclear localisation of mutant huntingtin in the YAC128 mouse model of Huntington's disease
    Van Raamsdonk, JM
    Murphy, Z
    Slow, EJ
    Leavitt, BR
    Hayden, MR
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
  • [22] Striosome-matrix pathology and motor deficits in the YAC128 mouse model of Huntington's disease
    Lawhorn, Collene
    Smith, Diane M.
    Brown, Lucy L.
    NEUROBIOLOGY OF DISEASE, 2008, 32 (03) : 471 - 478
  • [23] Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease
    Joshi, Prasad R.
    Wu, Nan-Ping
    Andre, Veronique M.
    Cummings, Damian M.
    Cepeda, Carlos
    Joyce, John A.
    Carroll, Jeffrey B.
    Leavitt, Blair R.
    Hayden, Michael R.
    Levine, Michael S.
    Bamford, Nigel S.
    JOURNAL OF NEUROSCIENCE, 2009, 29 (08): : 2414 - 2427
  • [24] Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease
    Van Raamsdonk, JM
    Murphy, Z
    Slow, EJ
    Leavitt, BR
    Hayden, MR
    HUMAN MOLECULAR GENETICS, 2005, 14 (24) : 3823 - 3835
  • [25] Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease
    Mazarei, Gelareh
    Budac, David P.
    Lu, Ge
    Adomat, Hans
    Guns, Emma S. Tomlinson
    Moeller, Thomas
    Leavitt, Blair R.
    JOURNAL OF NEUROCHEMISTRY, 2013, 127 (06) : 852 - 867
  • [26] In Vivo MRI Evidence that Neuropathology is Attenuated by Cognitive Enrichment in the Yac128 Huntington's Disease Mouse Model
    Steventon, Jessica J.
    Harrison, David J.
    Trueman, Rebecca C.
    Rosser, Anne E.
    Jones, Derek K.
    Brooks, Simon P.
    JOURNAL OF HUNTINGTONS DISEASE, 2015, 4 (02) : 149 - 160
  • [27] Antidepressant Effects of Probucol on Early-Symptomatic YAC128 Transgenic Mice for Huntington's Disease
    Nascimento-Castro, Cristine de Paula
    Wink, Ana Claudia
    da Fonseca, Victor Silva
    Bianco, Claudia Daniele
    Winkelmann-Duarte, Elisa C.
    Farina, Marcelo
    Rodrigues, Ana Lucia S.
    Gil-Mohapel, Joana
    de Bem, Andreza Fabro
    Brocardo, Patricia S.
    NEURAL PLASTICITY, 2018, 2018
  • [28] INVESTIGATION OF THE EFFECT OF LATENT TOXOPLASMA GONDII INFECTION ON STRIATAL NEURODEGENERATION IN THE YAC128 MOUSE MODEL OF HUNTINGTON'S DISEASE
    Jenkins, T. K.
    Donley, D. W.
    Fox, J. H.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (01) : 210 - 210
  • [29] Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin
    Pouladi, Mahmoud A.
    Graham, Rona K.
    Karasinska, Joanna M.
    Xie, Yuanyun
    Santos, Rachelle Dar
    Petersen, Asa
    Hayden, Michael R.
    BRAIN, 2009, 132 : 919 - 932
  • [30] Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease
    Carroll, Jeffrey B.
    Lerch, Jason P.
    Franciosi, Sonia
    Spreeuw, Amanda
    Bissada, Nagat
    Henkelman, R. Mark
    Hayden, Michael R.
    NEUROBIOLOGY OF DISEASE, 2011, 43 (01) : 257 - 265